Lower injection-related HIV-1 risk associated with participation in a harm reduction program in Kazan, Russia

AIDS Education and Prevention

Volumn 19, Issue 1, 2007, Pages 13-23

  Badrieva, Larissa ^a,b   Karchevsky, Eugeny ^b   Irwin, Kevin S ^c,d   Heimer, Robert ^c  

^a Ministry of Health   (Russian Federation)

^b Harm Reduction Project Renewal   (Russian Federation)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG USE; FEMALE; HEALTH CARE ORGANIZATION; HEALTH PRACTITIONER; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MEDICAL INFORMATION; MEDICAL PRACTICE; RUSSIAN FEDERATION; SYRINGE;

ADOLESCENT; ADULT; BLOOD-BORNE PATHOGENS; CROSS-SECTIONAL STUDIES; FEMALE; HARM REDUCTION; HIV INFECTIONS; HIV-1; HUMANS; INTERVIEWS; MALE; MIDDLE AGED; NEEDLE-EXCHANGE PROGRAMS; PROGRAM EVALUATION; RUSSIA; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 34247527882     PISSN: 08999546     EISSN: None     Source Type: Journal    
DOI: 10.1521/aeap.2007.19.1.13     Document Type: Article

References (22)

1. AIDS Foundation East-West. (2003a). AFEW epidemiology. Retrieved 15 September, 2004 at http://www.afew.org/index.php?page_id=32&lang_id=1
2. AIDS Foundation East-West. (2003b). AFEW harm reduction. Retrieved 15 September, 2004 at http://www.afew.org/index.php?page_id=83&lang_id=1
3. Badrieva, L., & Karchevsky, E. (2001). Building volunteer networks: Secondary needle exchange, peer education. Kazan, Russia: Project Renewal.
4. Brettle, R. P. (1990). Implications of the Edinburgh AIDS epidemic for the United Kingdom. Journal of Infection, 20, 215-217.
5. Broadhead, R. S., Heckathorn, D. D., Weakliem, D. L., Anthony, D. L., Madray, H., Mills, R. J., et al. (1998). Harnessing peer networks as an instrument for aids prevention: Results from a peer-driven intervention. Publ. Health Rpts., 113 (Suppl.), 42-57.
6. Burrows, D. (2000). Strategies for dealing with HIV/AIDS in the former Soviet Union. Development Bulletin, 52, 49-51.
7. Burrows, D. (2001). A best practice model of harm reduction in the community and in prisons in Russian Federation. Sydney, Australia: Médecins sans Frontières-Hollande.
8. Burrows, D., Zverev, V. V., & Sarankov, I. A. (2000). Harm reduction - Its history and practice [Russian]. Zhournal Mikrobiologii, Epidemiologii i Immunobiologii, 4, 65-69.
9. Des Jarlais, D. C., Friedman, S. R., Sotheran, J. L., Wenston, J., Marmor, M., Yancovitz, S. R., et al. (1994). Continuity and change within an HIV epidemic. Journal of the American Medical Association, 271(2), 121-127.
10. Des Jarlais, D. C., Grund, J.-P., Zadoretzky, C., Milliken, J., Friedmann, P., Titus, S., et al. (2002). Hiv risk behavior among participants of syringe exchange programmes in Central/Eastern Europe and Russia. International Journal of Drug Policy, 13, 165-174.
11. Des Jarlais, D. C., Hagan, H., Friedman, S. R., Friedmann, P., Goldberg, D., Frischer, M., et al. (1995). Maintaining low HIV seroprevalence in populations of injecting drug users. Journal of the American Medical Association, 274, 1226-1231.
12. Drucker, E., Lurie, P., Wodak, A., & Alcabes, P. (1998). Measuring harm reduction: The effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS (Suppl. A), S217-S230.
13. Hurley, S. F., Jolley, D. J., & Kaldor, J. M. (1997). Effectiveness of needle-exchange programmes for prevention of HIV infection. The Lancet, 349, 1797-1800.
14. Irwin, K., Kozlov, A. P., Grund, J.-P., Borodkina, O., Baranova, M., Guirtchenko, P., et al. (2003, April). Liquid drug manufacture and HIV in Russia. Paper presented at the 14th International Conference on the Reduction of Drug-Related Harm, Chiang Mai, Thailand.
15. Latkin, C. A. (1995). A personal network approach to aids prevention: An experimental peer group intervention for street-injecting drug users, the safe study. In R. H. Needle, S. G. Genser & R. T. Trotter II (Eds.), Social, networks, drug abuse, and HIV transmission (NIDA Research Monograph 151, pp. 181-195). Rockville, MD: U.S. Dept. of Health and Human Services.
16. Marmor, M., Des Jarlais, D. C., Cohen, H., Friedman, S. R., Beatrice, S. T., Dubin, N., et al. (1987). Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS, 1(1), 39-44.
17. Naik, T., Sarkar, S., Singh, H., Bhunia, S., Singh, Y., Singh, P., et al. (1991). Intravenous drug users - A new high-risk group for HIV infection in India. AIDS, 5(1), 116-117.
18. Neaigus, A. (1998). The network approach and interventions to prevent HIV among injection drug users. Public Health Reports, 113(Suppl. 1), 140-150.
19. Ostrovsky, D. (2000, May). Injection drug use, hiv, hepatitis, and overdose in st. Petersburg. Paper presented at the Eighth International Conference on AIDS, Cancer, and Related Problems, St. Petersburg, Russia.
20. Rhodes, T., Lowndes, C., Judd, A., Mikhailova, L., A, Sarang, A., Rylkov, A., et al. (2002). Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia. AIDS, 16, F25-F31.
21. Robertson, J., Bucknall, A., Welsby, P., Roberts, J., Inglis, J., Peutherer, J., et al. (1986). Epidemic of AIDS-related virus (HTLV-III/LAV) infection among intravenous drug abusers. British Medical Journal, 292, 527-529.
22. Schoenbaum, E. E., Hartel, D., Selwyn, P. A., Klein, R. S., Davenny, K., Rogers, M., et al. (1989). Risk factors for human immunodeficiency virus infection in intravenous drug users. New England Journal of Medicine, 321, 874-879.